Cura Therapeutics
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2150 Shattuck Ave Fl 3, Berkeley, Califo...Phone Number
(925) 330-1691Website
www.curatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
1
2
2
3
3
About Cura Therapeutics
Cura Therapeutics is focused on pioneering next-generation multimodal immunotherapies aimed at treating cancer and age-associated diseases to enhance healthspan and longevity. Their lead product, CT101, is a first-in-class recombinant protein that activates key immune mechanisms to combat metastatic cancers. The company's innovative approach combines immunostimulatory, anti-fibrotic, and anti-senescence activities, setting it apart from existing treatments. Cura Therapeutics is also seeking strategic partnerships with pharmaceutical and biotechnology firms to further develop and commercialize their cancer immunotherapies.Explore more
Popular SearchesCura TherapeuticsCura Therapeutics LLCCuratherapeuticsSIC Code 28,283NAICS Code 32,325Show more
Cura Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cura Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Cura Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Cura Therapeutics
Check out if Cura Therapeutics is spiking on competitors!
Click to see if Cura Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Cura Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cura Therapeutics has new funding data
Check if Cura Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cura Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Cura Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cura Therapeutics
Compare insights from companies similar to Cura Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cura Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Cura Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Cura Therapeutics.
Cura Therapeutics Tech Stack
A closer look at the technologies used by Cura Therapeutics
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cura Therapeutics
Sign Up For FreeTo access detailed company insights
Cura Therapeutics is focused on pioneering next-generation multimodal immunotherapies aimed at treating cancer and age-associated diseases to enhance healthspan and longevity. Their lead product, CT101, is a first-in-class recombinant protein that activates key immune mechanisms to combat metastatic cancers. The company's innovative approach combin... Read More
